AAAAAA

   
Results: 1-20 |
Results: 20
INHIBITORY ANTI-FACTOR-V ANTIBODIES BIND TO THE FACTOR-V C2 DOMAIN AND ARE ASSOCIATED WITH HEMORRHAGIC MANIFESTATIONS
Authors: ORTEL TL MOORE KD QUINNALLEN MA OKAMURA T SINCLAIR AJ LAZARCHICK J GOVINDAN R CARMAGNOL F KANE WH
Citation: Tl. Ortel et al., INHIBITORY ANTI-FACTOR-V ANTIBODIES BIND TO THE FACTOR-V C2 DOMAIN AND ARE ASSOCIATED WITH HEMORRHAGIC MANIFESTATIONS, Blood, 91(11), 1998, pp. 4188-4196
PROSPECTIVE EVALUATION OF ANTI-BOVINE THROMBIN ANTIBODY INDUCTION FOLLOWING SURGICAL EXPOSURE TO BOVINE THROMBIN
Authors: ORTEL TL NEAL MC THAMES EH MOORE K KLEMP K KANE WH LEE ML NAVALTA L LAWSON JH
Citation: Tl. Ortel et al., PROSPECTIVE EVALUATION OF ANTI-BOVINE THROMBIN ANTIBODY INDUCTION FOLLOWING SURGICAL EXPOSURE TO BOVINE THROMBIN, Thrombosis and haemostasis, 1997, pp. 966-966
PROTEIN-S SELECTIVELY ACCELERATES THE APC CATALYZED CLEAVAGE AT BOTH ARGININE-306 AND ARGININE-679 IN FACTOR VA
Authors: WEI CJ QUINNALLEN MA KANE WH
Citation: Cj. Wei et al., PROTEIN-S SELECTIVELY ACCELERATES THE APC CATALYZED CLEAVAGE AT BOTH ARGININE-306 AND ARGININE-679 IN FACTOR VA, Blood, 90(10), 1997, pp. 638-638
STUDIES OF A 2ND FAMILY WITH THE QUEBEC PLATELET DISORDER - EVIDENCE THAT THE DEGRADATION OF THE ALPHA-GRANULE MEMBRANE AND ITS SOLUBLE CONTENTS ARE NOT SECONDARY TO A DEFECT IN TARGETING PROTEINS TO ALPHA-GRANULES
Authors: HAYWARD CPM CRAMER EM KANE WH ZHENG SL BOUCHARD M MASSE JM RIVARD GE
Citation: Cpm. Hayward et al., STUDIES OF A 2ND FAMILY WITH THE QUEBEC PLATELET DISORDER - EVIDENCE THAT THE DEGRADATION OF THE ALPHA-GRANULE MEMBRANE AND ITS SOLUBLE CONTENTS ARE NOT SECONDARY TO A DEFECT IN TARGETING PROTEINS TO ALPHA-GRANULES, Blood, 89(4), 1997, pp. 1243-1253
FACTOR-V INHIBITORS ASSOCIATED WITH HEMORRHAGIC SYMPTOMS BIND TO A LIMITED REGION OF THE FACTOR VA LIGHT-CHAIN
Authors: ORTEL TL MOORE KD QUINNALLEN MA KANE WH
Citation: Tl. Ortel et al., FACTOR-V INHIBITORS ASSOCIATED WITH HEMORRHAGIC SYMPTOMS BIND TO A LIMITED REGION OF THE FACTOR VA LIGHT-CHAIN, Journal of investigative medicine, 44(3), 1996, pp. 233-233
EFFECT OF HETEROLOGOUS FACTOR-V HEAVY-CHAIN SEQUENCES ON THE SECRETION OF RECOMBINANT HUMAN FACTOR-VIII
Authors: ORTEL TL MOORE KD EZBAN M KANE WH
Citation: Tl. Ortel et al., EFFECT OF HETEROLOGOUS FACTOR-V HEAVY-CHAIN SEQUENCES ON THE SECRETION OF RECOMBINANT HUMAN FACTOR-VIII, Thrombosis and haemostasis, 75(1), 1996, pp. 36-44
SYSTEMATIC MUTAGENESIS OF ACTIVATED PROTEIN-C CLEAVAGE SITES IN FACTOR VA DEMONSTRATES THAT MULTIPLE CLEAVAGES ARE REQUIRED FOR COMPLETE INACTIVATION OF THE COFACTOR
Authors: WEI CJ QUINNALLEN MA KANE WH
Citation: Cj. Wei et al., SYSTEMATIC MUTAGENESIS OF ACTIVATED PROTEIN-C CLEAVAGE SITES IN FACTOR VA DEMONSTRATES THAT MULTIPLE CLEAVAGES ARE REQUIRED FOR COMPLETE INACTIVATION OF THE COFACTOR, Blood, 88(10), 1996, pp. 1751-1751
THE DEGRADATION OF THE ALPHA-GRANULE MEMBRANE AND ITS SOLUBLE CONTENTS IN THE QUEBEC, QUALITATIVE PLATELET DISORDER IS NOT SECONDARY TO A DEFECT IN TARGETING PROTEINS TO ALPHA-GRANULES
Authors: HAYWARD CPM CRAMER EM KANE WH ZHENG S BOUCHARD M MASSE JM RIVARD GE
Citation: Cpm. Hayward et al., THE DEGRADATION OF THE ALPHA-GRANULE MEMBRANE AND ITS SOLUBLE CONTENTS IN THE QUEBEC, QUALITATIVE PLATELET DISORDER IS NOT SECONDARY TO A DEFECT IN TARGETING PROTEINS TO ALPHA-GRANULES, Blood, 88(10), 1996, pp. 1859-1859
EXPRESSION AND CHARACTERIZATION OF RECOMBINANT FACTOR-V R506Q (FACTORV-LEIDEN)
Authors: WEI CJ QUINNALLEN MA KANE WH
Citation: Cj. Wei et al., EXPRESSION AND CHARACTERIZATION OF RECOMBINANT FACTOR-V R506Q (FACTORV-LEIDEN), Blood, 86(10), 1995, pp. 801-801
CLEAVAGE AT ARGININE-306 IS NOT REQUIRED FOR INACTIVATION OF FACTOR-VBY ACTIVATED PROTEIN-C (APC)
Authors: WEI CJ QUINNALLEN MA KANE WH
Citation: Cj. Wei et al., CLEAVAGE AT ARGININE-306 IS NOT REQUIRED FOR INACTIVATION OF FACTOR-VBY ACTIVATED PROTEIN-C (APC), Blood, 86(10), 1995, pp. 2446-2446
THROMBIN-CATALYZED ACTIVATION OF RECOMBINANT HUMAN FACTOR-V
Authors: KELLER FG ORTEL TL QUINNALLEN MA KANE WH
Citation: Fg. Keller et al., THROMBIN-CATALYZED ACTIVATION OF RECOMBINANT HUMAN FACTOR-V, Biochemistry, 34(12), 1995, pp. 4118-4124
TOPICAL THROMBIN AND ACQUIRED COAGULATION-FACTOR INHIBITORS - CLINICAL SPECTRUM AND LABORATORY DIAGNOSIS
Authors: ORTEL TL CHARLES LA KELLER FG MARCOM PK OLDHAM HN KANE WH MACIK BG
Citation: Tl. Ortel et al., TOPICAL THROMBIN AND ACQUIRED COAGULATION-FACTOR INHIBITORS - CLINICAL SPECTRUM AND LABORATORY DIAGNOSIS, American journal of hematology, 45(2), 1994, pp. 128-135
LOCALIZATION OF FUNCTIONALLY IMPORTANT EPITOPES WITHIN THE 2ND C-TYPEDOMAIN OF COAGULATION-FACTOR V USING RECOMBINANT CHIMERAS
Authors: ORTEL TL QUINNALLEN MA KELLER FG PETERSON JA LAROCCA D KANE WH
Citation: Tl. Ortel et al., LOCALIZATION OF FUNCTIONALLY IMPORTANT EPITOPES WITHIN THE 2ND C-TYPEDOMAIN OF COAGULATION-FACTOR V USING RECOMBINANT CHIMERAS, The Journal of biological chemistry, 269(22), 1994, pp. 15898-15905
EVALUATION OF PREANALYTICAL VARIABLES ASSOCIATED WITH MEASUREMENT OF PROTHROMBIN FRAGMENT-1.2
Authors: GREENBERG CS HURSTING MJ MACIK BG ORTEL TL KANE WH MOORE BM
Citation: Cs. Greenberg et al., EVALUATION OF PREANALYTICAL VARIABLES ASSOCIATED WITH MEASUREMENT OF PROTHROMBIN FRAGMENT-1.2, Clinical chemistry, 40(10), 1994, pp. 1962-1969
PURIFICATION AND CHARACTERIZATION OF THE 2ND C-TYPE DOMAIN OF HUMAN FACTOR-V EXPRESSED IN BACULOVIRUS
Authors: ORTEL TL QUINNALLEN MA KANE WH
Citation: Tl. Ortel et al., PURIFICATION AND CHARACTERIZATION OF THE 2ND C-TYPE DOMAIN OF HUMAN FACTOR-V EXPRESSED IN BACULOVIRUS, Blood, 84(10), 1994, pp. 10000387-10000387
PARTIAL GLYCOSYLATION AT ASPARAGINE-2181 OF THE 2ND C-TYPE DOMAIN OF HUMAN FACTOR-V IS THE STRUCTURAL BASIS OF THE LIGHT-CHAIN DOUBLET
Authors: ORTEL TL YOO L QUINNALLEN MA KANE WH
Citation: Tl. Ortel et al., PARTIAL GLYCOSYLATION AT ASPARAGINE-2181 OF THE 2ND C-TYPE DOMAIN OF HUMAN FACTOR-V IS THE STRUCTURAL BASIS OF THE LIGHT-CHAIN DOUBLET, Blood, 84(10), 1994, pp. 10000387-10000387
DDAVP IN ACQUIRED HEMOPHILIA-A - CASE-REPORT AND REVIEW OF THE LITERATURE
Authors: MUDAD R KANE WH
Citation: R. Mudad et Wh. Kane, DDAVP IN ACQUIRED HEMOPHILIA-A - CASE-REPORT AND REVIEW OF THE LITERATURE, American journal of hematology, 43(4), 1993, pp. 295-299
A FACTOR-V FACTOR-VIII LIGHT-CHAIN CHIMERA THAT EXPRESSES FACTOR-V PROCOAGULANT ACTIVITY AND IS RESISTANT TO NEUTRALIZATION BY A FACTOR-V INHIBITOR
Authors: ORTEL TL QUINNALLEN MA KELLER FG KANE WH
Citation: Tl. Ortel et al., A FACTOR-V FACTOR-VIII LIGHT-CHAIN CHIMERA THAT EXPRESSES FACTOR-V PROCOAGULANT ACTIVITY AND IS RESISTANT TO NEUTRALIZATION BY A FACTOR-V INHIBITOR, Thrombosis and haemostasis, 69(6), 1993, pp. 1046-1046
COMPLEMENT-INDUCED VESICULATION AND EXPOSURE OF MEMBRANE PROTHROMBINASE SITES IN PLATELETS OF PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA
Authors: WIEDMER T HALL SE ORTEL TL KANE WH ROSSE WF SIMS PJ
Citation: T. Wiedmer et al., COMPLEMENT-INDUCED VESICULATION AND EXPOSURE OF MEMBRANE PROTHROMBINASE SITES IN PLATELETS OF PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA, Blood, 82(4), 1993, pp. 1192-1196
FUNCTIONAL-CHARACTERIZATION OF THROMBIN CLEAVAGE SITES IN HUMAN COAGULATION FACTOR-V USING SITE-DIRECTED-MUTAGENESIS
Authors: KELLER FG ORTEL TL QUINNALLEN MA KANE WH
Citation: Fg. Keller et al., FUNCTIONAL-CHARACTERIZATION OF THROMBIN CLEAVAGE SITES IN HUMAN COAGULATION FACTOR-V USING SITE-DIRECTED-MUTAGENESIS, Blood, 82(10), 1993, pp. 10000338-10000338
Risultati: 1-20 |